Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Novel cancer therapies are offering patients new treatments and better outcomes worldwide. And recent changes in healthcare policies across APAC, such as China’s fast tracking approval of therapies for severe and rare diseases, have reignited interest in the APAC region as a strong market for oncology.
Are dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.
Therapy Watch Associate Director Raquel Nuñez, discusses continuing improvements in HIV therapies and the evolution of single-tablet regimens (STRs) over time.
Research Partnership welcomes four project management apprentices
We are delighted to announce that we have recruited 4 new Project Management Apprentices at our London office this month, in a collaboration with West London College.
Research Partnership launches new patient Living with Non-alcoholic Steatohepatitis (NASH) EU report
Living with Non-alcoholic Steatohepatitis (NASH) EU is a study conducted amongst 275 adults with NASH / NAFLD in France, Germany, Italy, Spain and UK. The report consists of 30-minute quantitative online and qualitative telephone interviews with patients and will be available to purchase in the first quarter of 2019.
Client Testimonial "This research was likely first in the industry and first to include all marketing functions..."
"This research was likely first in the industry and first to include all marketing functions. You assured us that next steps will get us the competitive advantage we need to remain leaders in the marketplace.”
Senior Manager, Business Analysis & Insights